Urticarial - What's New |
Conferences
eMediNexus Coverage from: 
Urticarial - What's New
Dr Kiran Godse, Mumbai,  23 January 2019
Coronavirus Live Count Map India

remove_red_eye 771 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Dermatology

0 Read Comments                

Urticaria is often autoimmune and autoallergic in chronic typeUpdosing of antihistamines is accepted second line therapy followed by omalizumab and cyclosporine as third and fourth line therapyAverage duration of chronic spontaneous Urticaria is 5 To 7 years in most cases....
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now